Besides, many studies have shown that the abnormal expression of LOXL2 in a variety of cancers is related to epithelial-mesenchymal transition, metastasis, poor prognosis, resistance to radiotherapy and chemotherapy, and tumor progression34. Here, LOXL2 is linked to cancer.